Dr. Ranine Ghamrawi, MD

Dr. Ghamrawi practices at Mid-Atlantic Endoscopy Center in Newark, Delaware.

Dr. Ghamrawi's NPI, 1821473109, was assigned on July 28, 2015. Dr. Ghamrawi holds Delaware license C1-0024171.

Dr. Ghamrawi's primary practice is Mid-Atlantic Endoscopy Center, at 4923 Ogletown-Stanton Road Suite 100, Newark, DE 19713. The practice phone is (302) 993-0310.

Dr. Ghamrawi's primary practice is Mid-Atlantic Endoscopy Center in Newark, Delaware. Dr. Ghamrawi is also affiliated with Christiana Hospital. The medical group on file is Nephrology Associates, P.A. Dmand AI also links Dr. Ghamrawi to 4 more hospitals, 3 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghamrawi practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Ghamrawi's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Ghamrawi is licensed in Delaware.

CMS data shows 2,257 Medicare services from Dr. Ghamrawi across 13 procedure codes in 2024, for 468 Medicare patients. Medicare paid $164,755 for them.

CMS counts 468 Medicare patients who saw Dr. Ghamrawi in 2024. The largest group is 75 to 84, with 181 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 4.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ghamrawi's median patient age at 71, with 50% women.

In 2024, Dr. Ghamrawi wrote 581 Medicare Part D claims for 141 patients. 86% of them were for generic drugs. CMS names the drug for 400 of them, across 16 drugs with 11 or more claims each, at $74,055 in total drug cost. In 2023, CMS named 233 claims across 9 drugs.

Dr. Ghamrawi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ghamrawi as offering telehealth.

Dmand AI links 10 papers to Dr. Ghamrawi, published from 2017 to 2022. 2020 was the busiest year, with 3. The most frequent topics are Kidney. Dr. Ghamrawi's most frequent co-authors are Vesna D. Garovic, MD, Jithma Prasad Abeykoon, MD and Shane Anthony Bobart, MD.

CMS Open Payments shows 153 general payments to Dr. Ghamrawi from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $8,156.